Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
New biologic agents: a critical appraisal.
B. E. Sands
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New biologic agents: a critical appraisal.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Biological Agents
100%
New Biologics
100%
Infliximab
66%
Clinical Trials
33%
Recombinant
33%
Clinical Data
33%
Inflammatory Bowel Disease
33%
Crohn's Disease
33%
Medical Therapy
33%
Biological Response Modifiers
33%
Large-scale Production
33%
Nursing and Health Professions
Biological Product
100%
Critical Appraisal
100%
Infliximab
66%
Inflammatory Bowel Disease
33%
Combination Therapy
33%
Crohn's Disease
33%
Biological Response Modifier
33%
Large Scale Production
33%
Medicine and Dentistry
Biological Product
100%
Critical Appraisal
100%
Infliximab
66%
Clinical Trial
33%
Combination Therapy
33%
Inflammatory Bowel Disease
33%
Crohn's Disease
33%
Biological Response Modifier
33%
Mathematics
Critical Appraisal
100%